Tyson V. Sharp

2.1k total citations
48 papers, 1.6k citations indexed

About

Tyson V. Sharp is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Tyson V. Sharp has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 19 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Tyson V. Sharp's work include RNA modifications and cancer (10 papers), Cancer, Hypoxia, and Metabolism (7 papers) and RNA Research and Splicing (7 papers). Tyson V. Sharp is often cited by papers focused on RNA modifications and cancer (10 papers), Cancer, Hypoxia, and Metabolism (7 papers) and RNA Research and Splicing (7 papers). Tyson V. Sharp collaborates with scholars based in United Kingdom, United States and India. Tyson V. Sharp's co-authors include Michael J. Clemens, Ian W. Jeffrey, Rosemary Jagus, Dimitris Lagos, Hsei–Wei Wang, Kunal Shah, Chris Boshoff, Tristan R. McKay, Daniel Yee and Ken Laing and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Tyson V. Sharp

46 papers receiving 1.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Tyson V. Sharp 958 347 335 317 275 48 1.6k
Marc Lipinski 1.8k 1.9× 306 0.9× 212 0.6× 413 1.3× 150 0.5× 67 2.6k
Archibald S. Perkins 1.2k 1.2× 425 1.2× 161 0.5× 255 0.8× 274 1.0× 42 2.3k
Timothy Myles 631 0.7× 178 0.5× 255 0.8× 314 1.0× 162 0.6× 74 2.3k
Li‐Ru You 1.3k 1.4× 269 0.8× 232 0.7× 243 0.8× 392 1.4× 38 2.2k
Oliver Coutelle 934 1.0× 249 0.7× 218 0.7× 167 0.5× 105 0.4× 25 1.4k
Deborah J. Vestal 1.1k 1.1× 356 1.0× 275 0.8× 1.0k 3.2× 165 0.6× 28 2.2k
John R. Doedens 1.2k 1.2× 279 0.8× 160 0.5× 244 0.8× 139 0.5× 17 1.9k
Lucienne Ronco 645 0.7× 462 1.3× 209 0.6× 918 2.9× 478 1.7× 27 1.7k
Louise Barnett 1.1k 1.1× 242 0.7× 94 0.3× 605 1.9× 314 1.1× 36 2.0k
Christian Beltinger 1.3k 1.3× 449 1.3× 410 1.2× 303 1.0× 270 1.0× 57 2.0k

Countries citing papers authored by Tyson V. Sharp

Since Specialization
Citations

This map shows the geographic impact of Tyson V. Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyson V. Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyson V. Sharp more than expected).

Fields of papers citing papers by Tyson V. Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tyson V. Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyson V. Sharp. The network helps show where Tyson V. Sharp may publish in the future.

Co-authorship network of co-authors of Tyson V. Sharp

This figure shows the co-authorship network connecting the top 25 collaborators of Tyson V. Sharp. A scholar is included among the top collaborators of Tyson V. Sharp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tyson V. Sharp. Tyson V. Sharp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maniati, Eleni, et al.. (2025). The DNA mismatch repair protein, MSH6 is a novel regulator of PD-L1 expression. Neoplasia. 67. 101207–101207.
2.
Hewitson, James P., Kunal Shah, Najmeeyah Brown, et al.. (2019). miR‐132 suppresses transcription of ribosomal proteins to promote protective Th1 immunity. EMBO Reports. 20(4). 13 indexed citations
3.
Feber, Andrew, Ankur Chakravarthy, Patricia de Winter, et al.. (2016). CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma. Cancer Research. 76(16). 4720–4727. 45 indexed citations
4.
Warner, Matthew J., James P. Hewitson, Michael R. Hodgkinson, et al.. (2016). S6K2-mediated regulation of TRBP as a determinant of miRNA expression in human primary lymphatic endothelial cells. Nucleic Acids Research. 44(20). gkw631–gkw631. 17 indexed citations
5.
Dermit, Maria, Pedro Casado, Vinothini Rajeeve, et al.. (2016). Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition. Oncogene. 36(19). 2762–2774. 26 indexed citations
6.
Shah, Kunal, et al.. (2015). Suppression of AGO2 by miR-132 as a determinant of miRNA-mediated silencing in human primary endothelial cells. The International Journal of Biochemistry & Cell Biology. 69. 75–84. 25 indexed citations
7.
Hawkins, Kate, Tyson V. Sharp, & Tristan R. McKay. (2013). The Role of Hypoxia in Stem Cell Potency and Differentiation. Regenerative Medicine. 8(6). 771–782. 58 indexed citations
8.
Maiti, Guru Prasad, Jaydip Biswas, Anup Roy, et al.. (2013). Reduction of Proliferation and Induction of Apoptosis are Associated with Shrinkage of Head and Neck Squamous Cell Carcinoma due to Neoadjuvant Chemotherapy. Asian Pacific Journal of Cancer Prevention. 14(11). 6419–6425. 10 indexed citations
9.
Gkouskou, Kalliopi, et al.. (2013). SUMOylation Is Required for Optimal TRAF3 Signaling Capacity. PLoS ONE. 8(11). e80470–e80470. 5 indexed citations
10.
Foxler, Daniel E., Victoria James, Maureen Mee, et al.. (2012). The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity. Nature Cell Biology. 14(2). 201–208. 73 indexed citations
11.
James, Victoria, et al.. (2011). MicroRNA-mediated gene silencing: are we close to a unifying model?. BioMolecular Concepts. 3(1). 29–40. 3 indexed citations
12.
McKay, Tristan R., Banu İskender, Nicola Bates, et al.. (2011). Human feeder cell line for derivation and culture of hESc/hiPSc. Stem Cell Research. 7(2). 154–162. 15 indexed citations
13.
Foxler, Daniel E., Victoria James, Samuel J. Shelton, et al.. (2011). PU.1 is a major transcriptional activator of the tumour suppressor geneLIMD1. FEBS Letters. 585(7). 1089–1096. 11 indexed citations
14.
Leonard, Paul G., Tyson V. Sharp, Stephen Henderson, et al.. (2003). Gene expression array profile of human osteosarcoma. British Journal of Cancer. 89(12). 2284–2288. 24 indexed citations
15.
Sharp, Tyson V. & Chris Boshoff. (2000). Kaposi's Sarcoma‐Associated Herpesvirus: From Cell Biology to Pathogenesis. IUBMB Life. 49(2). 97–104. 13 indexed citations
16.
Sharp, Tyson V., et al.. (1999). Activation of the Interferon-Inducible (2′-5′) Oligoadenylate Synthetase by the Epstein–Barr Virus RNA, EBER-1. Virology. 257(2). 303–313. 26 indexed citations
17.
18.
Sharp, Tyson V., Qiurong Xiao, Just Justesen, Dirk R. Gewert, & Michael J. Clemens. (1995). Regulation of the Interferon‐indueible Protein Kinase PKR and (2′‐5′)oligo(Adenylate) Synthetase by a Catalytically Inactive PKR Mutant Through Competition for Double‐stranded RNA Binding. European Journal of Biochemistry. 230(1). 97–103. 10 indexed citations
19.
Sharp, Tyson V., et al.. (1994). The La antigen inhibits the activation of the interferoninducible protein kinase PKR by sequestering and unwinding double-stranded RNA. Nucleic Acids Research. 22(13). 2512–2518. 52 indexed citations
20.
Sharp, Tyson V., Martin Schwemmle, Ian W. Jeffrey, et al.. (1993). Comparative analysis of the regulation of the interferoninducible protein kinase PKR by Epstein - Barr virus RNAs EBER-1 and EBER-2 and adenovirus VA, RNA. Nucleic Acids Research. 21(19). 4483–4490. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Lipinski Breakdown of academic impact, for papers by Archibald S. Perkins Breakdown of academic impact, for papers by Timothy Myles Breakdown of academic impact, for papers by Li‐Ru You Breakdown of academic impact, for papers by Oliver Coutelle Breakdown of academic impact, for papers by Deborah J. Vestal Breakdown of academic impact, for papers by John R. Doedens Breakdown of academic impact, for papers by Lucienne Ronco Breakdown of academic impact, for papers by Louise Barnett Breakdown of academic impact, for papers by Christian Beltinger
Rankless by CCL
2026